AllStripes offers a platform for data sharing among patients with rare diseases, doctors and researchers.

AllStripes aggregates and analyzes medical records and sells the de-identified data to pharmaceutical companies to help them develop medicines. In exchange for access to the data, patients gets their fragmented medical records organized into an app they can use to track their treatment and get second opinions.

• Industry

  • Digital Health

• Milestones

  • Lux investment: 2018

• Founders

  • Nancy Yu
  • Onno Faber

  LUX Partners

  • Adam Goulburn
  • Deena Shakir

• Latest Tweets

  • Caitrin’s daughter Embree passed away from Sandhoff disease, a form of GM2 gangliosidosis. The family has taken ste… https://t.co/2gTKZD0YkX@_allstripes - 4h
  • Take a look at @_AllStripes’ list of some favorite links relevant to the rare disease community ↓ https://t.co/N6HQZayVFi@_allstripes - 11h
  • Crigler-Najjar syndrome type 1 is an ultra-rare disease that was first reported in medical literature in 1952 by Dr… https://t.co/kWieEa4xK8@_allstripes - 04:14 PM Jul 28th